Possible roles of DLK1 in the Notch pathway during development and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 988-995

  Falix, Farah A ^a,b   Aronson, Daniël C ^b   Lamers, Wouter H ^a   Gaemers, Ingrid C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Adipose tissue; Development; DLK1; Liver; Notch pathway; Pediatric tumor

Indexed keywords

DELTA LIKE 1 HOMOLOG; DELTA LIKE 3 HOMOLOG; DELTA LIKE 4 HOMOLOG; JAGGED1; JAGGED2; LIGAND; MEMBRANE PROTEIN; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG;

ADIPOGENESIS; DISEASE COURSE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MORPHOGENESIS; NEPHROBLASTOMA; NEUROBLASTOMA; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC DEVELOPMENT; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84859098510     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.003     Document Type: Review

References (117)

1. Altenberger T., Bilban M., Auer M., Knosp E., Wolfsberger S., Gartner W., Mineva I., Zielinski C., Wagner L., Luger A. Identification of DLK1 variants in pituitary- and neuroendocrine tumors. Biochem. Biophys. Res. Commun. 2006, 340:995-1005.
2. Andersen D.C., Petersson S.J., Jorgensen L.H., Bollen P., Jensen P.B., Teisner B., Schroeder H.D., Jensen C.H. Characterization of DLK1+ cells emerging during skeletal muscle remodeling in response to myositis, myopathies, and acute injury. Stem Cells 2009, 27:898-908.
3. Apelqvist A., Li H., Sommer L., Beatus P., Anderson D.J., Honjo T., Hrabe de A.M., Lendahl U., Edlund H. Notch signalling controls pancreatic cell differentiation. Nature 1999, 400:877-881.
4. Artavanis-Tsakonas S., Matsuno K., Fortini M.E. Notch signaling. Science 1995, 268:225-232.
5. Artavanis-Tsakonas S., Muskavitch M.A. Notch: the past, the present, and the future. Curr. Top. Dev. Biol. 2010, 92:1-29.
6. Artavanis-Tsakonas S., Muskavitch M.A., Yedvobnick B. Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:1977-1981.
7. Artavanis-Tsakonas S., Simpson P. Choosing a cell fate: a view from the Notch locus. Trends Genet. 1991, 7:403-408.
8. Baladron V., Ruiz-Hidalgo M.J., Nueda M.L., az-Guerra M.J., Garcia-Ramirez J.J., Bonvini E., Gubina E., Laborda J. dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp. Cell Res. 2005, 303:343-359.
9. Boehmer von H. Coming to grips with Notch. J. Exp. Med. 2001, 194:F43-F46.
10. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 2006, 7:678-689.
11. Bray S.J., Takada S., Harrison E., Shen S.C., Ferguson-Smith A.C. The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev. Biol. 2008, 8:11.
12. Buas M.F., Kadesch T. Regulation of skeletal myogenesis by Notch. Exp. Cell Res. 2010, 316:3028-3033.
13. Bulman M.P., Kusumi K., Frayling T.M., McKeown C., Garrett C., Lander E.S., Krumlauf R., Hattersley A.T., Ellard S., Turnpenny P.D. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat. Genet. 2000, 24:438-441.
14. Cairo S., Armengol C., De R.A., Wei Y., Thomas E., Renard C.A., Goga A., Balakrishnan A., Semeraro M., Gresh L., Pontoglio M., Strick-Marchand H., Levillayer F., Nouet Y., Rickman D., Gauthier F., Branchereau S., Brugieres L., Laithier V., Bouvier R., Boman F., Basso G., Michiels J.F., Hofman P., rbez-Gindre F., Jouan H., Rousselet-Chapeau M.C., Berrebi D., Marcellin L., Plenat F., Zachar D., Joubert M., Selves J., Pasquier D., Bioulac-Sage P., Grotzer M., Childs M., Fabre M., Buendia M.A. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008, 14:471-484.
15. Ceder J.A., Jansson L., Helczynski L., Abrahamsson P.A. Delta-like 1 (Dlk-1), a novel marker of prostate basal and candidate epithelial stem cells, is downregulated by notch signalling in intermediate/transit amplifying cells of the human prostate. Eur. Urol. 2008, 54:1344-1353.
16. Charlier C., Segers K., Karim L., Shay T., Gyapay G., Cockett N., Georges M. The callipyge mutation enhances the expression of coregulated imprinted genes in cis without affecting their imprinting status. Nat. Genet. 2001, 27:367-369.
17. Chen J., Crabbe A., Van Duppen V., Vankelecom H. The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population. Mol. Endocrinol. 2006, 20:3293-3307.
18. Conlon R.A., Reaume A.G., Rossant J. Notch1 is required for the coordinate segmentation of somites. Development 1995, 121:1533-1545.
19. Cowherd R.M., Lyle R.E., McGehee R.E. Molecular regulation of adipocyte differentiation. Semin. Cell Dev. Biol. 1999, 10:3-10.
20. Croquelois A., Blindenbacher A., Terracciano L., Wang X., Langer I., Radtke F., Heim M.H. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology 2005, 41:487-496.
21. D'Souza B., Miyamoto A., Weinmaster G. The many facets of Notch ligands. Oncogene 2008, 27:5148-5167.
22. Davis E., Jensen C.H., Schroder H.D., Farnir F., Shay-Hadfield T., Kliem A., Cockett N., Georges M., Charlier C. Ectopic expression of DLK1 protein in skeletal muscle of padumnal heterozygotes causes the callipyge phenotype. Curr. Biol. 2004, 14:1858-1862.
23. Deiuliis J.A., Li B., Lyvers-Peffer P.A., Moeller S.J., Lee K. Alternative splicing of delta-like 1 homolog (DLK1) in the pig and human. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2006, 145:50-59.
24. Dezso K., Halasz J., Bisgaard H.C., Paku S., Turanyi E., Schaff Z., Nagy P. Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas. Virchows Arch. 2008, 452:443-448.
25. Dikic I., Schmidt M.H. Notch: implications of endogenous inhibitors for therapy. Bioessays 2010, 32:481-487.
26. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T., Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004, 18:2730-2735.
27. Dunwoodie S.L., Clements M., Sparrow D.B., Sa X., Conlon R.A., Beddington R.S. Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 2002, 129:1795-1806.
28. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., Sklar J. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66:649-661.
29. Falix F., Aronson D., Hiralall K., Lamers W., Seppen J. DLK1, a serum marker for hepatoblastoma in young infants. Pediatr. Blood Cancer 2011, doi:10.1002/pbc.24024. [Epub ahead of print].
30. Fehon R.G., Kooh P.J., Rebay I., Regan C.L., Xu T., Muskavitch M.A., Artavanis-Tsakonas S. Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell 1990, 61:523-534.
31. Floridon C., Jensen C.H., Thorsen P., Nielsen O., Sunde L., Westergaard J.G., Thomsen S.G., Teisner B. Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation 2000, 66:49-59.
32. Fukuzawa R., Heathcott R.W., Morison I.M., Reeve A.E. Imprinting, expression, and localisation of DLK1 in Wilms tumours. J. Clin. Pathol. 2005, 58:145-150.
33. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., Yancopoulos G.D. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15949-15954.
34. Garces C., Ruiz-Hidalgo M.J., Bonvini E., Goldstein J., Laborda J. Adipocyte differentiation is modulated by secreted delta-like (dlk) variants and requires the expression of membrane-associated dlk. Differentiation 1999, 64:103-114.
35. Garces C., Ruiz-Hidalgo M.J., Font de M.J., Park C., Miele L., Goldstein J., Bonvini E., Porras A., Laborda J. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J. Biol. Chem. 1997, 272:29729-29734.
36. Gasperowicz M., Otto F. The notch signalling pathway in the development of the mouse placenta. Placenta 2008, 29:651-659.
37. Geisler F., Nagl F., Mazur P.K., Lee M., Zimber-Strobl U., Strobl L.J., Radtke F., Schmid R.M., Siveke J.T. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 2008, 48:607-616.
38. Guseh J.S., Bores S.A., Stanger B.Z., Zhou Q., Anderson W.J., Melton D.A., Rajagopal J. Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development 2009, 136:1751-1759.
39. Hald J., Hjorth J.P., German M.S., Madsen O.D., Serup P., Jensen J. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev. Biol. 2003, 260:426-437.
40. Hamada Y., Kadokawa Y., Okabe M., Ikawa M., Coleman J.R., Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 1999, 126:3415-3424.
41. Horowitz A., Simons M. Branching morphogenesis. Circ. Res. 2008, 103:784-795.
42. Hrabe de A.M., McIntyre J., Gossler A. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 1997, 386:717-721.
43. Jensen C.H., Meyer M., Schroder H.D., Kliem A., Zimmer J., Teisner B. Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk. Neuroreport 2001, 12:3959-3963.
44. Jensen C.H., Teisner B., Hojrup P., Rasmussen H.B., Madsen O.D., Nielsen B., Skjodt K. Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum. Reprod. 1993, 8:635-641.
45. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 2000, 24:36-44.
46. Jiang R., Lan Y., Chapman H.D., Shawber C., Norton C.R., Serreze D.V., Weinmaster G., Gridley T. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev. 1998, 12:1046-1057.
47. Katsube K., Sakamoto K. Notch in vertebrates-molecular aspects of the signal. Int. J. Dev. Biol. 2005, 49:369-374.
48. Kim K.A., Kim J.H., Wang Y., Sul H.S. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol. Cell. Biol. 2007, 27:2294-2308.
49. Kitamoto T., Takahashi K., Takimoto H., Tomizuka K., Hayasaka M., Tabira T., Hanaoka K. Functional redundancy of the Notch gene family during mouse embryogenesis: analysis of Notch gene expression in Notch3-deficient mice. Biochem. Biophys. Res. Commun. 2005, 331:1154-1162.
50. Komatsu H., Chao M.Y., Larkins-Ford J., Corkins M.E., Somers G.A., Tucey T., Dionne H.M., White J.Q., Wani K., Boxem M., Hart A.C. OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development. PLoS Biol. 2008, 6:e196.
51. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
52. Kortschak R.D., Tamme R., Lardelli M. Evolutionary analysis of vertebrate Notch genes. Dev. Genes Evol. 2001, 211:350-354.
53. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14:1343-1352.
54. Laborda J. The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol. Histopathol. 2000, 15:119-129.
55. Larsen J.B., Jensen C.H., Schroder H.D., Teisner B., Bjerre P., Hagen C. Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet 1996, 347:191.
56. Lee K., Villena J.A., Moon Y.S., Kim K.H., Lee S., Kang C., Sul H.S. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J. Clin. Invest. 2003, 111:453-461.
57. Lewis J. Notch signalling and the control of cell fate choices in vertebrates. Semin. Cell Dev. Biol. 1998, 9:583-589.
58. Limpt van V., Chan A., Caron H., Sluis P.V., Boon K., Hermus M.C., Versteeg R. SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene. Med. Pediatr. Oncol. 2000, 35:554-558.
59. Limpt van V., Chan A.J., Van Sluis P.G., Caron H.N., Van Noesel C.J., Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int. J. Cancer 2003, 105:61-69.
60. Litten J., Chen T., Schultz R., Schiffman J., Hermann K., Tomlinson G., Rakheja D. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study. Pediatr. Dev. Pathol. 2011.
61. Loomes K.M., Taichman D.B., Glover C.L., Williams P.T., Markowitz J.E., Piccoli D.A., Baldwin H.S., Oakey R.J. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am. J. Med. Genet. 2002, 112:181-189.
62. Lopez-Terrada D. Integrating the diagnosis of childhood malignancies. Adv. Exp. Med. Biol. 2006, 587:121-137.
63. Lopez-Terrada D., Gunaratne P.H., Adesina A.M., Pulliam J., Hoang D.M., Nguyen Y., Mistretta T.A., Margolin J., Finegold M.J. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum. Pathol. 2009, 40:783-794.
64. Luo J.H., Ren B., Keryanov S., Tseng G.C., Rao U.N., Monga S.P., Strom S., Demetris A.J., Nalesnik M., Yu Y.P., Ranganathan S., Michalopoulos G.K. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006, 44:1012-1024.
65. Mann J.R., Kasthuri N., Raafat F., Pincott J.R., Parkes S.E., Muir K.R., Ingram L.C., Cameron A.H. Malignant hepatic tumours in children: incidence, clinical features and aetiology. Paediatr. Perinat. Epidemiol. 1990, 4:276-289.
66. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., Herzlinger D., Weinmaster G., Jiang R., Gridley T. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
67. McCright B., Lozier J., Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129:1075-1082.
68. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., Spinner N.B. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 2006, 79:169-173.
69. Mei B., Zhao L., Chen L., Sul H.S. Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing. Biochem. J. 2002, 364:137-144.
70. Miyaoka Y., Tanaka M., Imamura T., Takada S., Miyajima A. A novel regulatory mechanism for Fgf18 signaling involving cysteine-rich FGF receptor (Cfr) and delta-like protein (Dlk). Development 2010, 137:159-167.
71. Moon Y.S., Smas C.M., Lee K., Villena J.A., Kim K.H., Yun E.J., Sul H.S. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol. Cell. Biol. 2002, 22:5585-5592.
72. Nicolas M., Wolfer A., Raj K., Kummer J.A., Mill P., van N.M., Hui C.C., Clevers H., Dotto G.P., Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 2003, 33:416-421.
73. Nueda M.L., Baladron V., Garcia-Ramirez J.J., Sanchez-Solana B., Ruvira M.D., Rivero S., Ballesteros M.A., Monsalve E.M., Diaz-Guerra M.J., Ruiz-Hidalgo M.J., Laborda J. The novel gene EGFL9/Dlk2, highly homologous to Dlk1, functions as a modulator of adipogenesis. J. Mol. Biol. 2007, 367:1270-1280.
74. Nueda M.L., Baladron V., Sanchez-Solana B., Ballesteros M.A., Laborda J. The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells. J. Mol. Biol. 2007, 367:1281-1293.
75. Puertas-Avendano R.A., Gonzalez-Gomez M.J., Ruvira M.D., Ruiz-Hidalgo M.J., Morales-Delgado N., Laborda J., Diaz C., Bello A.R. Role of the non-canonical notch ligand delta-like protein 1 in hormone-producing cells of the adult male mouse pituitary. J. Neuroendocrinol. 2011, 23:849-859.
76. Qi X., Chen Z., Liu D., Cen J., Gu M. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells. Int. J. Mol. Med. 2008, 22:61-68.
77. Radtke F., Wilson A., Stark G., Bauer M., van M.J., MacDonald H.R., Aguet M. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
78. Raghunandan R., Ruiz-Hidalgo M., Jia Y., Ettinger R., Rudikoff E., Riggins P., Farnsworth R., Tesfaye A., Laborda J., Bauer S.R. Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev. 2008, 17:495-507.
79. Rebay I., Fleming R.J., Fehon R.G., Cherbas L., Cherbas P., Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 1991, 67:687-699.
80. Reik W., Constancia M., Dean W., Davies K., Bowden L., Murrell A., Feil R., Walter J., Kelsey G. Igf2 imprinting in development and disease. Int. J. Dev. Biol. 2000, 44:145-150.
81. Rockett J.C., Patrizio P., Schmid J.E., Hecht N.B., Dix D.J. Gene expression patterns associated with infertility in humans and rodent models. Mutat. Res. 2004, 549:225-240.
82. Ross D.A., Hannenhalli S., Tobias J.W., Cooch N., Shiekhattar R., Kadesch T. Functional analysis of Hes-1 in preadipocytes. Mol. Endocrinol. 2006, 20:698-705.
83. Ross D.A., Rao P.K., Kadesch T. Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol. Cell. Biol. 2004, 24:3505-3513.
84. Rowland J.M. Hepatoblastoma: assessment of criteria for histologic classification. Med. Pediatr. Oncol. 2002, 39:478-483.
85. Ruck P., Xiao J.C. Stem-like cells in hepatoblastoma. Med. Pediatr. Oncol. 2002, 39:504-507.
86. Ruck P., Xiao J.C., Pietsch T., Von S.D., Kaiserling E. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 1997, 31:324-329.
87. Ruiz-Hidalgo M.J., Gubina E., Tull L., Baladron V., Laborda J. dlk modulates mitogen-activated protein kinase signaling to allow or prevent differentiation. Exp. Cell Res. 2002, 274:178-188.
88. Sakajiri S., O'kelly J., Yin D., Miller C.W., Hofmann W.K., Oshimi K., Shih L.Y., Kim K.H., Sul H.S., Jensen C.H., Teisner B., Kawamata N., Koeffler H.P. Dlk1 in normal and abnormal hematopoiesis. Leukemia 2005, 19:1404-1410.
89. Sanchez-Solana B., Nueda M.L., Ruvira M.D., Ruiz-Hidalgo M.J., Monsalve E.M., Rivero S., Garcia-Ramirez J.J., Diaz-Guerra M.J., Baladron V., Laborda J. The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities. Biochim. Biophys. Acta 2011, 1813:1153-1164.
90. Schuster-Gossler K., Cordes R., Gossler A. Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:537-542.
91. Sheng H.Z., Westphal H. Early steps in pituitary organogenesis. Trends Genet. 1999, 15:236-240.
92. Shimizu K., Chiba S., Kumano K., Hosoya N., Takahashi T., Kanda Y., Hamada Y., Yazaki Y., Hirai H. Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods. J. Biol. Chem. 1999, 274:32961-32969.
93. Shimizu K., Chiba S., Saito T., Kumano K., Hirai H. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 2000, 276:385-389.
94. Smas C.M., Chen L., Sul H.S. Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. Mol. Cell. Biol. 1997, 17:977-988.
95. Smas C.M., Sul H.S. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993, 73:725-734.
96. Smas C.M., Sul H.S. Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1. Crit. Rev. Eukaryot. Gene Expr. 1997, 7:281-298.
97. Suskind D.L., Murray K.F. Increasing the mutation rate for Jagged1 mutations in patients with Alagille syndrome. Hepatology 2007, 46:598-599.
98. Swiatek P.J., Lindsell C.E., del Amo F.F., Weinmaster G., Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev. 1994, 8:707-719.
99. Tanimizu N., Miyajima A. Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J. Cell Sci. 2004, 117:3165-3174.
100. Tanimizu N., Nishikawa M., Saito H., Tsujimura T., Miyajima A. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J. Cell Sci. 2003, 116:1775-1786.
101. Theodosiou A., Arhondakis S., Baumann M., Kossida S. Evolutionary scenarios of Notch proteins. Mol. Biol. Evol. 2009, 26:1631-1640.
102. Tornehave D., Jansen P., Teisner B., Rasmussen H.B., Chemnitz J., Moscoso G. Fetal antigen 1 (FA1) in the human pancreas: cell type expression, topological and quantitative variations during development. Anat. Embryol. (Berl) 1993, 187:335-341.
103. Tsao P.N., Chen F., Izvolsky K.I., Walker J., Kukuruzinska M.A., Lu J., Cardoso W.V. Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. J. Biol. Chem. 2008, 283:29532-29544.
104. Vasyutina E., Lenhard D.C., Birchmeier C. Notch function in myogenesis. Cell Cycle 2007, 6:1451-1454.
105. Vasyutina E., Lenhard D.C., Wende H., Erdmann B., Epstein J.A., Birchmeier C. RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4443-4448.
106. Vessey C.J., de la Hall P.M. Hepatic stem cells: a review. Pathology 2001, 33:130-141.
107. Voss J.W., Rosenfeld M.G. Anterior pituitary development: short tales from dwarf mice. Cell 1992, 70:527-530.
108. Waddell J.N., Zhang P., Wen Y., Gupta S.K., Yevtodiyenko A., Schmidt J.V., Bidwell C.A., Kumar A., Kuang S. Dlk1 is necessary for proper skeletal muscle development and regeneration. PLoS One 2010, 5:e15055.
109. Wang Y., Sul H.S. Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation. Mol. Cell. Biol. 2006, 26:5421-5435.
110. Wang Y., Zhao L., Smas C., Sul H.S. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol. Cell. Biol. 2010, 30:3480-3492.
111. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
112. Yanai H., Nakamura K., Hijioka S., Kamei A., Ikari T., Ishikawa Y., Shinozaki E., Mizunuma N., Hatake K., Miyajima A. Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J. Biochem. 2010, 148:85-92.
113. Yevtodiyenko A., Schmidt J.V. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev. Dyn. 2006, 235:1115-1123.
114. Zhang H., Noohr J., Jensen C.H., Petersen R.K., Bachmann E., Teisner B., Larsen L.K., Mandrup S., Kristiansen K. Insulin-like growth factor-1/insulin bypasses Pref-1/FA1-mediated inhibition of adipocyte differentiation. J. Biol. Chem. 2003, 278:20906-20914.
115. Zhu X., Zhang J., Tollkuhn J., Ohsawa R., Bresnick E.H., Guillemot F., Kageyama R., Rosenfeld M.G. Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev. 2006, 20:2739-2753.
116. Zong Y., Panikkar A., Xu J., Antoniou A., Raynaud P., Lemaigre F., Stanger B.Z. Notch signaling controls liver development by regulating biliary differentiation. Development 2009, 136:1727-1739.
117. Zweidler-McKay P.A. Notch signaling in pediatric malignancies. Curr. Oncol. Rep. 2008, 10:459-468.